Noam Edward Kopmar, Jonathan R. Fromm, Noah Pinke, Christen Martino, Ashtyn Sherrow, Cristina Maria Ghiuzeli, Raya Mawad, Ted Gooley, Jason Phillip Cooper, Erik Lesley Kimble, Bart L. Scott, Paul Hendrie, Johnnie J. Orozco, Joshua Veatch, Mary-Elizabeth M. Percival, Ryan Daniel Cassaday. "Initial results from a phase II study of dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-EPOCH) ± rituximab (R) + tafasitamab (tafa) for adults with newly-diagnosed (ND) Philadelphia chromosome negative (Ph-) B lymphoblastic leukemia (B-ALL).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6540